Literature DB >> 17568034

Echinocandins--first-choice or first-line therapy for invasive candidiasis?

Jack D Sobel, Sanjay G Revankar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568034     DOI: 10.1056/NEJMe078078

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Clinical aspects of invasive candidiasis in critically ill patients.

Authors:  Mariano Pennisi; Massimo Antonelli
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 2.  Invasive fungal infections in transplant recipients.

Authors:  Jose A Vazquez; Marisa H Miceli; George Alangaden
Journal:  Ther Adv Infect Dis       Date:  2013-06

Review 3.  Treatment of candidemia in adult patients without neutropenia--an inconvenient truth.

Authors:  Pedro Póvoa; João Gonçalves-Pereira
Journal:  Crit Care       Date:  2011-01-31       Impact factor: 9.097

4.  Management of invasive candidiasis in the intensive care unit.

Authors:  E Geoffrey Playford; Jeff Lipman; Tania C Sorrell
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

5.  Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.

Authors:  Jiun-Ling Wang; Chia-Hsuin Chang; Yinong Young-Xu; K Arnold Chan
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

6.  Anidulafungin in the treatment of invasive fungal infections.

Authors:  Kathryn Sabol; Tawanda Gumbo
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

7.  Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.

Authors:  Sibel Ascioglu; K Arnold Chan
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.